Article info
PDFClinical ethics
Using biomarkers in acute medicine to prevent hearing loss: should this require specific consent?
- Correspondence to Professor Anneke Lucassen, CELS, University of Southampton Faculty of Medicine, Southampton SO16 6YD, UK; a.m.lucassen{at}soton.ac.uk
Citation
Using biomarkers in acute medicine to prevent hearing loss: should this require specific consent?
Publication history
- Received February 26, 2020
- Accepted March 11, 2020
- First published July 13, 2020.
Online issue publication
July 23, 2020
Article Versions
- Previous version (13 July 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Other content recommended for you
- Using a biomarker acutely to identify babies at risk of serious adverse effects from antibiotics: where is the ‘Terrible Moral and Medical Dilemma’?
- Terrible choices in the septic child: a response to the PALOH trial round table authors
- Pharmacogenetics to Avoid Loss of Hearing (PALOH) trial: a protocol for a prospective observational implementation trial
- Genetic testing in the acute setting: a round table discussion
- Beyond regulatory approaches to ethics: making space for ethical preparedness in healthcare research
- Genetic testing without consent: the implications of the new Human Tissue Act 2004
- Mind the gap: are NHS trusts falling short of recommended standards for consent to autopsy?
- Research involving storage and use of human tissue: how did the Human Tissue Act 2004 affect decisions by research ethics committees?
- Barriers to the release of human tissue for clinical trials research in the UK: a national survey of cellular pathology laboratories on behalf of the National Cancer Research Institute’s Cellular Molecular Pathology (CM-Path) initiative
- Licenced to transplant: UK overkill on EU Organ Directive provides golden opportunity for research